Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Theravance Biopharma, Inc. (NASDAQ: TBPH) to participate in Fireside Chat at Evercore ISI HealthCONx Conference

DUBLIN, Nov. 15, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the 6^th Annual Evercore ISI HealthCONx Conference Tuesday, November 28 at 1:45 pm EST (10:45 am PST/6:45 pm GMT) and will be hosting in-person meetings with the investment community at the conference.

A Webcast of the event may be accessed by visiting Theravance.com, under the Investors section: Presentations and Events. A Replay of the webcast will be archived on the Company's website for 30 days.

About Theravance Biopharma 

Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference^® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI^® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension, has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in multiple symptom atrophy patients. The Company is committed to creating/driving shareholder value.

For more information, please visit www.theravance.com.

THERAVANCE BIOPHARMA^®, THERAVANCE^®, and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).

YUPELRI^® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing on this press release are the property of their respective owners.

Contact:
investor.relations@theravance.com
650-808-4045

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-the-6th-annual-evercore-isi-healthconx-conference-301988516.html

SOURCE THERAVANCE BIOPHARMA US, INC.

FAQ

What is Theravance Biopharma, Inc. participating in at the Evercore ISI HealthCONx Conference?

Theravance Biopharma, Inc. will participate in a Fireside Chat and host in-person meetings with the investment community at the conference.

When and where will the Fireside Chat take place?

The Fireside Chat will take place on Tuesday, November 28 at 1:45 pm EST (10:45 am PST/6:45 pm GMT) at the Evercore ISI HealthCONx Conference.

How can the webcast of the event be accessed?

The webcast may be accessed by visiting Theravance.com, under the Investors section: Presentations and Events.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be archived on the Company's website for 30 days.